Christopher Bowden Alaunos Therapeutics, Inc. (TCRT) insider trading activity

TCRT Quotes by TradingView

Christopher Bowden is Director of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 44,167 shares of TCRT, which is worth approximately $106,884. The most recent transaction as insider was on Jun 22, 2022, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.2K
0% 3M change
0% 12M change
Total Value Held $106,884

Christopher Bowden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 47.52%
44,167 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
4,167 Added 50.0%
4,167 Common Stock

Also insider at

AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Chief Medical Officer
CB

Christopher Bowden

Director
Cambridge, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRT